| Date Filed | Type | Description |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/29/2021 |
4
| Doberstein Stephen K (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $15.61, valued at
$390.3k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 06/07/2021 |
4
| Doberstein Stephen K (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Exercised 3,333 restricted stock units
@ $0
Granted 3,333 restricted stock units
@ $0
Granted 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 06/16/2020 |
4
| Doberstein Stephen K (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 3,333 restricted stock units
@ $0
Granted 15,000 options to buy
@ $21.61, valued at
$324.2k
|
|
| 03/16/2020 |
4
| Doberstein Stephen K (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $15.61, valued at
$390.3k
|
|
| 02/11/2020 |
3
| Doberstein Stephen K (Director) has filed a Form 3 on Dicerna Pharmaceuticals Inc |
| 09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2019 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 3,245 shares
@ $18.15, valued at
$58.9k
|
|
| 05/17/2019 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 3,461 shares
@ $31.37, valued at
$108.6k
|
|
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2018 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 23,950 shares
@ $0
Granted 48,400 options
@ $36.51, valued at
$1.8M
|
|
| 11/19/2018 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 4,524 shares
@ $38.25, valued at
$173k
|
|
| 08/16/2018 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 26,000 shares
@ $0
Disposed/sold 6,701 shares
@ $58.4, valued at
$391.3k
Granted 65,000 options to buy
@ $56.9, valued at
$3.7M
|
|
| 05/18/2018 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 3,435 shares
@ $83.39, valued at
$286.4k
|
|
| 04/09/2018 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 110,500 shares
@ $91.69, valued at
$10.1M
Sold 49,500 shares
@ $96.13, valued at
$4.8M
Exercised 60,000 options to buy
@ $10.69, valued at
$641.4k
Exercised 50,000 options to buy
@ $7.21, valued at
$360.5k
Exercised 500 options to buy
@ $7.21, valued at
$3.6k
Exercised 49,500 options to buy
@ $7.21, valued at
$356.9k
|
|
| 02/20/2018 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 2,426 shares
@ $82.94, valued at
$201.2k
|
|
| 12/19/2017 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 26,000 shares
@ $0
Granted 65,000 options
@ $56.9, valued at
$3.7M
|
|
| 11/17/2017 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 17,500 shares
@ $0
Disposed/sold 4,782 shares
@ $44.23, valued at
$211.5k
Granted 43,750 options to buy
@ $14.41, valued at
$630.4k
|
|
| 11/08/2017 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 20,914 shares
@ $24.98, valued at
$522.4k
Sold 75,409 shares
@ $25.78, valued at
$1.9M
Sold 300,000 shares
@ $30.09, valued at
$9M
Exercised 20,914 options to buy
@ $9.53, valued at
$199.3k
Exercised 75,409 options to buy
@ $9.53, valued at
$718.6k
Exercised 300,000 options to buy
@ $9.53, valued at
$2.9M
|
|
| 10/10/2017 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 43,677 shares
@ $24.97, valued at
$1.1M
Exercised 43,677 options to buy
@ $9.53, valued at
$416.2k
|
|
| 08/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2016 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 1,336 shares
@ $17.56, valued at
$23.5k
|
|
| 07/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/18/2016 |
4
| Doberstein Stephen K (SVP & Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Exercised 875 shares
@ $0.0001, valued at
$0.1
Sold 390 shares
@ $11.92, valued at
$4.6k
Disposed/sold 875 restricted stock units
@ $0.0001, valued at
$0.1 |
|
| 02/10/2011 |
4
| Doberstein Stephen K (Chief Scientific Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 60,000 options
@ $10.69, valued at
$641.4k
|
|
| 01/06/2010 |
3
| Doberstein Stephen K (Chief Scientific Officer) has filed a Form 3 on NEKTAR THERAPEUTICS |